2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation
Atherosclerosis is considered a chronic inflammatory disease of the arterial wall. Recently,
compelling evidence has arisen for the role of monocytes and neutrophils and a particular …
compelling evidence has arisen for the role of monocytes and neutrophils and a particular …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
[PDF][PDF] 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
Effect of platelet inhibition with cangrelor during PCI on ischemic events
Background The intensity of antiplatelet therapy during percutaneous coronary intervention
(PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a …
(PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a …
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
Background Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and
can affect the long-term prognosis of patients. To our knowledge, ticagrelor has not been …
can affect the long-term prognosis of patients. To our knowledge, ticagrelor has not been …
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis
Context Clinicians and trialists have difficulty with identifying which patients are highest risk
for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes …
for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes …
Acute myocardial infarction
GW Reed, JE Rossi, CP Cannon - The Lancet, 2017 - thelancet.com
Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …
elevation myocardial infarction; however, therapies are similar between the two, and the …